explore -WSS

explore

author：knowledge 2025-09-10 08:41:28 - browse：5

An orange Flovent inhaler on a white background. -- health coverage from STAT — Adobe

As of Jan. 1, thousands of asthma patients in the U.S. will no longer be able to get refills for Flovent — one of the most popular inhalers in the U.S. for nearly 30 years.

Flovent’s manufacturer, GSK, has discontinued both versions of the product — Flovent HFA, an inhalation aerosol, and Flovent Diskus, an inhalation powder — and replaced each with what is known as an “authorized generic,” essentially the same product sold under a private label. Prasco, a U.S. drugmaker specializing in authorized generics, will distribute the new inhaler, sold as fluticasone.

The timing of the change is telling: Flovent’s price rose nearly 50% since 2014, according to GoodRx, leaving the drug vulnerable to the new Medicaid penalties going into effect as of this year for medications with price increases that outpace inflation. By discontinuing the brand-name inhaler but continuing to earn money from the authorized generic, GSK will be able to avoid paying a penalty.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Medicare drug price negotiation continues, as pharma counteroffers

leisure time

WSS

Congress needs to close a vaccine

Ancient Greek ideas underpin modern concepts of pregnancy

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

UnitedHealth CEO's Medicaid comments send insurer stocks diving

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Harvard's David Sinclair gets blowback over aging

focus

explore

focus

How one medical school became remarkably diverse

Stem cell biologist probes earliest stages of human development

Affirmative action in medical school literally saved lives

Medicare drug price negotiation hearing pits pharma v Biden admin

Medical leaders decry Supreme Court decision on affirmative action

Streamlined flu vaccines recommended by FDA advisory panel

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Ozempic has benefits for kidney disease as well as diabetes

Cancer drug shortages should be causing more outrage

The untold story of TV’s first prescription drug ad

knowledge

How CO2 helps viruses stay alive longer in the air

STAT wants to know your pick for a great summer read or listen

First over

First over

Sutter Health’s antitrust win overturned by appeals court

Immune cells and nerve overgrowth may explain recurring UTI pain

focus

focus

leisure time

entertainment